New Drug Approvals

Home » cfda » EFAVIRENZ – Huahai Pharma China-Approved to Produce AIDS Treatment

EFAVIRENZ – Huahai Pharma China-Approved to Produce AIDS Treatment

DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO .....FOR BLOG HOME CLICK HERE

PAYPAL DONATIONS

ORGANIC SPECTROSCOPY

Read all about Organic Spectroscopy on ORGANIC SPECTROSCOPY INTERNATIONAL 

Categories

Blog Stats

  • 1,310,010 hits

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 1,782 other followers

add to any

Share

File:Efavirenz skeletal.svg

Efavirenz

DMP 266

Efavirenz, L-743725((+)-enantiomer), DMP-266, L-741211(racemate), L-743726, Stocrin, Sustiva
(S)-(-)-6-Chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one
154598-52-4

Generic brands India:

Zhejiang Huahai Pharma received CFDA approval to produce efavirenz, an oral non-nucleoside reverse transcriptase inhibitor (NNRTI) used to control the symptoms of AIDS. Huahai is the first China drugmaker approved to make the drug. Huahai produced efavirenz API for Merck, which marketed the drug under the name Stocrin

read at

http://www.sinocast.com/readbeatarticle.do?id=99634

Efavirenz (EFV), sold under the brand names Sustiva among others, is a non-nucleoside reverse transcriptase inhibitor (NNRTI). It is used as part of highly active antiretroviral therapy (HAART) for the treatment of a human immunodeficiency virus (HIV) type 1. For HIV infection that has not previously been treated, the United States Department of Health and Human Services Panel on Antiretroviral Guidelines currently recommends the use of efavirenz in combination with tenofovir/emtricitabine (Truvada) as one of the preferred NNRTI-based regimens in adults and adolescents.[1] Efavirenz is also used in combination with other antiretroviral agents as part of an expanded postexposure prophylaxis regimen to reduce the risk of HIV infection in people exposed to a significant risk (e.g. needlestick injuries, certain types of unprotected sex etc.).

It is usually taken on an empty stomach at bedtime to reduce neurological and psychiatric adverse effects.

Efavirenz was combined with the HIV medications tenofovir and emtricitabine, all of which are reverse transcriptase inhibitors. This combination of three medications under the brand name Atripla, provides HAART in a single tablet taken once a day.

Efavirenz was discovered at Merck Research Laboratories. It is on the WHO Model List of Essential Medicines, the most important medication needed in a basic health system.[2] As of 2015 the cost for a typical month of medication in the United States is more than 200 USD.[3]

 

Efavirenz (EFV, brand names SustivaStocrinEfavir etc.) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) and is used as part of highly active antiretroviral therapy(HAART) for the treatment of a human immunodeficiency virus (HIV) type 1.

For HIV infection that has not previously been treated, the United States Department of Health and Human Services Panel on Antiretroviral Guidelines currently recommends the use of efavirenz in combination with tenofovir/emtricitabine (Truvada) as one of the preferred NNRTI-based regimens in adults and adolescents.

Efavirenz is also used in combination with other antiretroviral agents as part of an expanded postexposure prophylaxis regimen to reduce the risk of HIV infection in people exposed to a significant risk (e.g. needlestick injuries, certain types of unprotected sex etc.).

The usual adult dose is 600 mg once a day. It is usually taken on an empty stomach at bedtime to reduce neurological and psychiatric adverse effects.

Efavirenz was combined with the popular HIV medication Truvada, which consists oftenofovir and emtricitabine, all of which are reverse transcriptase inhibitors. This combination of three medications approved by the U.S. Food and Drug Administration(FDA) in July 2006 under the brand name Atripla, provides HAART in a single tablet taken once a day. It results in a simplified drug regimen for many patients.

 

doi:10.1016/0040-4039(95)01955-H

Merck synthesis of Efavirenz

 

 

History

Efavirenz was approved by the FDA on September 21, 1998, making it the 14th approved antiretroviral drug.

  •  Efavirenz is a non-nucleoside reverse trancriptase inhibitor being studied clinically for use in the treatment of HIV infections and AIDS.
  • Efavirenz chemically known as (-) 6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl- 1 , 4- dihydro-2H-3, 1-benzoxa zin-2-one, is a highly potent non-nucleoside reverse transcriptase inhibitor (NNRTI).A number of compounds are effective in the treatment of the human immunodeficiency virus (HIV) which is the retrovirus that causes progressive destruction of the human immune system. Effective treatment through inhibition of HIV reverse transcriptase is known for non- nucleoside based inhibitors. Benzoxazinones have been found to be useful non-nucleoside based inhibitors of HIV reverse transcriptase.(-) β-chloro^-cyclopropylethynyM-trifluoromethyl-l ,4-dihydro-2H-3,l -ben zoxazin-2-one (Efavirenz) is efficacious against HIV reverse transcriptase resistance. Due to the importance of (-)6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-l,4-dihydro-2H-3,l-ben zoxazin-2- one, economical and efficient synthetic processes for its production needs to be developed.The product patent US5519021. discloses the preparation of Efavirenz, in Example-6, column-29, involving cyclisation of racemic mixture of 2-(2-amino-5-chlorophenyl)-4- cyclopropyl-l,l,l-trifluoro-3-butyn-2-ol using l ,l ‘-carbonyldiimidazole as carbonyl delivering agent to give racemic Efavirenz. Further, resolution of the racemic Efavirenz is carried out using (-) camphanic acid chloride to yield optically pure Efavirenz. However, research article published in the Drugs of the future, 1998, 23(2), 133-141 discloses process for manufacture of optically pure Efavirenz. The process involves cyclisation of racemic 2-(2-amino-5-chlorophenyl)-4-cyclopropyl-l, 1, l-trifluoro-3-butyn-2- ol using 1, 1-carbonyldiimidazole as carbonyl delivering agent to give racemic Efavirenz and further resolution by (-) camphanic acid chloride.Similarly research article published in Synthesis 2000, No. 4, 479-495 discloses stereoselective synthesis of Efavirenz (95%yield, 99.5%ee), as shown below
    Figure imgf000003_0001

    Even though many prior art processes report method for the preparation of Efavirenz, each process has some limitations with respect to yield, purity, plant feasibility etc. Hence in view of the commercial importance of Efavirenz there remains need for an improved process.

  • US 6 028 237 discloses a process for the manufacture of optically pure Efavirenz.
  • The synthesis of efavirenz and structurally similar reverse transcriptase inhibitors are disclosed in US Patents 5,519,021, 5,663,169, 5,665,720 and the corresponding PCT International Patent Application WO 95/20389, which published on August 3, 1995. Additionally, the asymmetric synthesis of an enantiomeric benzoxazinone by a highly enantioselective acetylide addition and cyclization sequence has been described by Thompson, et al., Tetrahedron Letters 1995, 36, 8937-8940, as well as the PCT publication, WO 96/37457, which published on November 28, 1996.
  • Additionally, several applications have been filed which disclose various aspects of the synthesis of(-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one including: 1) a process for making the chiral alcohol, U.S.S.N. 60/035,462, filed 14 January 1997; 2) the chiral additive, U.S.S.N. 60/034,926, filed 10 January 1997; 3) the cyclization reaction, U.S.S.N. 60/037,059, filed 12 February 1997; and the anti-solvent crystallization procedure, U.S.S.N. 60/037,385 filed 5 February 1997 and U.S.S.N. 60/042,807 filed 8 April 1997.

Efavirenz has been obtained by two related ways: 1) The acylation of 4-chloroaniline (I) with pivaloyl chloride (II) by means of Na2CO3 in toluene gives the expected anilide (III), which is acylated with ethyl trifluoroacetate by means of butyllithium in THF yielding, after hydrolysis with HCl, 2′-amino-5′-chloro-2,2,2-trifluoroacetophenone (IV). The benzylation of (IV) with 4-methoxybenzyl chloride (V) in basic alumina affords the protected acetophenone (VI), which is regioselectively condensed with cyclopropylacetylene (VII) [obtained by cyclization of 5-chloro-1-pentyne (VIII) by means of butyllithium in cyclohexane] by means of butyllithium in THF in the presence of (1R,2S)-1-phenyl-2-(1-pyrrolidinyl)-1-propanol (IX) giving the (S)-isomer of the tertiary alcohol (X) exclusively. The cyclization of (X) with phosgene and triethylamine or K2CO3 in toluene/THF yields the benzoxazinone (XI), which is finally deprotected with ceric ammonium nitrate in acetonitrile/water. 2) The condensation of 2′-amino-5′-chloro-2,2,2-trifluoroacetophenone (IV) with cyclopropylacetylene (VIII) by means of butyllithium or ethylmagnesium bromide in THF gives (?-2-(2-amino-5-chlorophenyl)-4-cyclopropyl-1,1,1-trifluoro-3-butyn-2-ol (XII). The cyclization of (XII) with carbonyldiimidazole (XIII) in hot THF yields the racemic benzoxazinone (XIV). Compound (XIV) is submitted to optical resolution by condensation with (S)-(-)-camphanoyl chloride by means of dimethylaminopyridine (DMAP) in dichloromethane to give the acyl derivative (XVI) as a diastereomeric mixture that is resolved by crystallization and finally decomposed with HCl in ethanol or butanol.
Corley, E.G.; Thompson, A.S.; Huntington, M.F.; Grabowski, E.J.J.; Use of an ephedrine alkoxide to mediate enantioselective addition of an acetylide to a prochiral ketone: Asymmetric synthesis of the reverse transcriptase inhibitor L-743,726.
Tetrahedron Lett1995,36,(49):8937-40
EP 1332757 A1
Clips
When a commercial market already exists for the RMs used in synthesizing an API, their cost can be rather modest. When RMs used in synthesizing an API have no other commercial use, however, they can contribute very substantially to API cost. With a continued growth of volume demand, improved chemistry and competition from multiple suppliers, however, the cost of API RMs can greatly decrease over time. The inhibitor of HIV-1 RT, EFV, provides an illustration of this situation. Cyclopropylacetylene (CPA) is an RM for the synthesis of EFV (Figure 4). During clinical trials, when the demand for CPA was only a few metric tons, this material was produced at a price of USD800–1,350/kg. When the drug was first approved in 1998, and demand for CPA was about 50 metric tons per year, the price of CPA had fallen to USD350/kg. Today, with global demand for EFV at greater than 1,000 metric tons/year, CPA can be purchased for about USD50–60/kg. In the earliest stages of production, nearly 1 kg of CPA was needed to produce a kilogram of EFV. Current production processes are more efficient; roughly 3 kg of EFV is now produced for each 1 kg of CPA used. From this it can be roughly estimated that the contribution of CPA to the cost of EFV API production has fallen from as high as USD425/kg to about USD17–20/kg today.
https://i1.wp.com/www.intmedpress.com/journals/avt/iframePopup_fig.cfm
The most recent chemistry for asymmetric alkynylation of manufacturing EFV uses inexpensive, safe reagents and processing at ambient temperature to reach EFV pricing that would have been thought impossible when the drug was launched by Dupont Pharmaceuticals in 1998
Biao J, Yugui S. inventors; Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, assignee. Amino alcohol ligand and its use in preparation of chiral propargylic tertiary alcohols and tertiary amines via enantioselective addition reaction. US Patent 7,439,400. 2008 October 21.
Bollu RB, Ketavarapu NR, Indukuri VSK, Gorantla SR, Chava S. inventors; Laurus Labs Private Limited, assignee. Efficient process to induce enantioselectivity in procarbonyl compounds. US Patent Application 2012/0264933 A1. 2012 October 18.
FPPs for adult ART are usually capsules or tablets. A general rule-of-thumb is that an FPP as a conventional, solid oral dosage formulation costs about 33–40% more than the corresponding API in a competitive market. It has been widely quoted, conversely, that APIs contribute about 60–80% of the cost of an FPP. The API contribution to FPP cost increases with the complexity of synthesis and API cost per kilogram. Although marketing is a substantial incremental cost for originator pharmaceutical companies, generic producers do not incur high marketing costs for ART.

Syntheses of EFV API; different routes of manufacturingAPI, active pharmaceutical ingredient; EFV efavirenz. BELOW

https://i1.wp.com/www.intmedpress.com/journals/avt/iframePopup_fig.cfmhttps://i1.wp.com/www.intmedpress.com/journals/avt/iframePopup_fig.cfm

Related substances and degradants (partial listing) in EFVAPI, active pharmaceutical ingredient; CPA, cyclopropylacetylene; EFV, efavirenz

Syntheses of EFV API; different routes of manufacturingAPI, active pharmaceutical ingredient; EFV efavirenz.

illustrates the great effect of new routes of synthesis on API costs. The manufacturing cost of route 1 for the launch of EFV in 1998 was about USD1,800/kg [31,41]. EFV API was priced at about USD1,100/kg for the first generic launch in 2005. At this time the price of CPA was about USD250/kg. The best prices for EFV API in 2012–2013 are USD120–130/kg prepared under GMP. This drastic 89% reduction in generic API pricing is due in part to volume demand – the LMIC use of generic EFV in 2012 exceeded 750 metric tons and was estimated to exceed 900 metric tons in 2013. Reductions in the cost of RMs have also had a significant effect. More efficient processes for producing the final intermediate SD 573, have contributed the largest part to price reductions [42]. The route 1 synthesis requires five steps while routes 2 through 4 require only two steps from the same starting materials for the commercial production of EFV.

Chemical properties

Efavirenz is chemically described as (S)-6-chloro-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one. Its empirical formula is C14H9ClF3NO2. Efavirenz is a white to slightly pink crystalline powder with a molecular mass of 315.68 g/mol. It is practically insoluble in water (<10 µg/mL).

History

Efavirenz was approved by the FDA on September 21, 1998, making it the 14th approved antiretroviral drug.

Society and culture

Pricing information

A one-month supply of 600 mg tablets cost approximately $550 in April 2008.[16] Merck provides efavirenz in certain developing countries at cost, currently about $0.65 per day.[17] Some emerging countries have opted to purchase Indian generics[18] such as Efavir by Cipla Ltd.[19] In Thailand, one month supply of efavirenz + truvada, as of June 2012, costs THB 2900 ($90), there’s also a social program for poorer patients who can’t afford even this price. In South Africa, a license has been granted to generics giant Aspen Pharmacare to manufacture, and distribute to Sub-Saharan Africa, a cost-effective antiretroviral drug.[20]

 PATENT

http://www.google.com/patents/WO1999061026A1?cl=en

EXAMPLE 1

Cl

1a

To a solution of trifluoroethanol and (IR, 2S)-N-pyrrolidinyl norephedrine in THF (9 L) under nitrogen is added a solution of diethylzinc in hexane at 0 °C slowly enough to keep the temperature below 30 °C. The mixture is stirred at room temperature for 0.5 ~ 1 h. In another dry flask a solution of chloromagnesium cyclopropyl acetylide is prepared as follows: To neat cyclopropyl acetylene at 0 °C is added a solution of rc-butylmagnesium chloride slowly enough to keep the internal temperature < 30 °C. The solution is stirred at 0 °C for ~ 40 min and transfered to the zinc reagent via cannula with 0.36 L of THF as a wash. The mixture is cooled to -10 °C and ketoaniline la is added. The mixture is stirred at -2 to -8 °C for 35 h, warmed to room temperature, stirred for 3 h, and quenched with 30% potassium carbonate over 1.5 h. The mixture is stirred for 4 h and the solid is removed by filtration and washed with THF (2 cake volume). The wet solid still contains -18 wt% of pyrrolidinyl norephedrine and is saved for further study. The filtrate and wash are combined and treated with 30% citric acid. The two layers are separated. The organic layer is washed with water (1.5 L). The combined aqueous layers are extracted with 2.5 L of toluene and saved for norephedrine recovery. The toluene extract is combined with the organic solution and is concentrated to ~ 2.5 L. Toluene is continuously feeded and distilled till THF is not detectable by GC. The final volume is controlled at 3.9 L. Heptane (5.2 L) is added over 1 h. The slurry is cooled to 0 °C, aged for 1 h, and filtered. The solid is washed with heptane (2 cake volume) and dried to give 1.234 Kg (95.2% yield) of amino alcohol 3 as a white crystalline. The material is 99.8 A% pure and 99.3% ee.

EXAMPLE 2

To a three necked round bottom flask, equipped with a mechanical stirrer, nitrogen line, and thermocouple, was charged the solid amino alcohol 3, MTBE (500 L), and aqueous KHCO3 (45 g in 654 mL H2O). Solid 4-nitrophenyl chloroformate was added, in 4 batches, at 25°C. During the addition the solution pH was monitored. The pH was maintained between 8.5 and 4 during the reaction and ended up at 8.0. The mixture was stirred at 20-25°C for two hours. Aqueous KOH (2N) was added over 20 minutes, until the pH of the aqueous layer reached 11.0.

The layers were separated and 500 mL brine was added to the MTBE layer. 0.1 N Acetic acid was added until the pH was 6-7. The layers were separated and the organic phase was washed with brine (500 mL). At this point the mixture was solvent switched to EtOH/IPA and crystallized as recited in Examples 5 and 6.

EXAMPLE 3

To a three necked round bottom flask, equipped with a mechanical stirrer, nitrogen line, and thermocouple, was charged the solid amino alcohol 3a, toulene (500 mL), and aqueous KHCO3 (86.5 g in 500 L H2O). Phosgene solution in toulene was added at 25°C, and the mixture was stirred at 20-25°C for two hours.

The layers were separated and the organic phase was washed with brine (500 mL). At this point the mixture was solvent switched to EtOH/IPA and crystallized as recited in Examples 5 and 6.

EXAMPLE 4

To a three necked round bottom flask, equipped with a mechanical stirrer, nitrogen line, and thermocouple, was charged the solid amino alcohol 3a, MTBE (500 mL), and aqueous KHCO3 (86.5 g in 500 mL H2O). Phosgene gas was slowly passed into the solution at 25°C, until the reaction was complete.

The layers were separated and the organic phase was washed with brine (500 mL). At this point the mixture was solvent switched to EtOH/IPA and crystallized as recited in Examples 5 and 6.

EXAMPLE 5

Crystallization of efavirenz from 30% 2-Propanol in Water using a ratio of 15 ml solvent per gram efavirenz Using Controlled Anti-Solvent Addition on a 400 g Scale.

400 g. of efavirenz starting material is dissolved in 1.8 L of 2- propanol. The solution is filtered to remove extraneous matter. 1.95 L of deionized (DI) water is added to the solution over 30 to 60 minutes. 10 g. to 20 g. of efavirenz seed (Form II wetcake) is added to the solution. The seed bed is aged for 1 hour. The use of Intermig agitators is preferred to mix the slurry. If required (by the presence of extremely long crystals or a thick slurry), the slurry is wet-milled for 15 – 60 seconds. 2.25 L of DI water is added to the slurry over 4 to 6 hours. If required (by the presence of extremely long crystals or a thick slurry), the slurry is wet- milled for 15 – 60 seconds during the addition. The slurry is aged for 2 to 16 hours until the product concentration in the supernatant remains constant. The slurry is filtered to isolate a crystalline wet cake. The wet cake is washed with 1 to 2 bed volumes of 30 % 2-propanol in water and then twice with 1 bed volume of DI water each. The washed wet cake is dried under vacuum at 50°C.

EXAMPLE 6

Crystallization of efavirenz from 30% 2-Propanol in Water using a ratio of 15 ml solvent per gram efavirenz Using a Semi-Continuous Process on a 400 g Scale.

400 g. of efavirenz starting material is dissolved in 1.8 L of 2- propanol. A heel slurry is produced by mixing 20 g. of Form II efavirenz in 0.3 L of 30 % (v/v) 2-propanol in water or retaining part of a slurry froma previous crystallization in the crystallizer. The dissolved batch and 4.2 L of DI water are simultaneously charged to the heel slurry at constant rates over 6 hours to maintain a constant solvent composition in the crystallizer. Use of Intermig agitators during the crystallization is preferred. During this addition the slurry is wet-milled when the crystal lengths become excessively long or the slurry becomes too thick. The slurry is aged for 2 to 16 hours until the product concentration in the supernatant remains constant. The slurry is filtered to isolate a crystalline wet cake. The wet cake is washed with 1 to 2 bed volumes of 30 % 2-propanol in water and then twice with 1 bed volume of DI water each. The washed wet cake is dried under vacuum at 50°C.

EXAMPLE 7 Preparation of Amino Alcohol 3 and ee Upgrading— Through Process

1a

A solution of diethyl zinc in hexane was added to a solution of trifluoroethanol (429.5 g, 4.29’mol) and (IR, 2S)-N-pyrrolidinyl norephedrine (1.35 kg, 6.58 mol) in THF (9 L), under nitrogen, at 0 °C. The resulting mixture was stirred at room temperature for approx. 30 min. In another dry flask a solution of chloromagnesium- cyclopropylacetylide was prepared as follows. To a solution of n- butylmagnesium chloride in THF (2 M, 2.68 L, 5.37 mol) was added neat cyclopropylacetylene at 0 °C keeping the temperature < 25 °C. The solution was stirred at 0 °C for 1 ~ 2 h. The solution of chloromagnesiumcyclopropylacetylide was then warmed to room temperature and was transferred into the zinc reagent via cannula over 5 min followed by vessel rinse with 0.36 L of THF. The resulting mixture was aged at ~ 30 °C for 0.5 h and was then cooled to 20 °C. The ketoaniline 1 (1.00 kg, 4.47 mol) was added in one portion as a solid, and the resulting mixture was stirred at 20-28 °C for 3 h.

The reaction was quenched with 30% aq. potassium carbonate (1.2 L) and aged for 1 h. The solid waste was filtered and the cake was washed with THF (3 cake volumes). The filtrate and wash were combined and solvent switched to IP Ac.

The IPAc solution of product 3 and pyrrolidinyl norephedrine was washed with citric acid (3.5 L) and with water (1.5 L). The combined aqueous layers were extracted with IPAc (2 L) and saved for norephedrine recovery. To the combined organic layers was added

12N HC1 (405 mL, 4.88 mol), to form a thin slurry of the amino alcohol-

HC1 salt. The mixture was aged for 30 min at 25 °C and was then dried azeotropically. The slurry was aged at 25 °C for 30 min and filtered. The cake was washed with 2.5 L of IPAc and dried at 25 °C under vacuum/nitrogen for 24 h to give 1.76 kg of the wet HC1 salt.

The salt was dissolved in a mixture of MTBE (6 L) and aq Na2Cθ3 (1.18 kg in 6.25 L water). The layers were separated and the organic layer was washed with 1.25 L of water. The organic layer was then solvent switched into toluene.

Heptane (5 L) was added over 1 h at 25 °C. The slurry was cooled to 0 °C, aged for 1 h, and filtered. The solid was washed with heptane (2 cake volumes) and was dried to give 1.166 kg (90% overall yield) of amino alcohol 3 as a white crystalline solid. Norephedrine recovery

The aqueous solution was basified to pH13 using 50% aq NaOH, and extracted with heptane (2 L). The heptane solution was washed with water (1 L) and concentrated to remove residual IPAc and water. The final volume was adjusted to about 3 L. The heptane solution was cooled to -20 °C, aged for 2 h, and filtered. The solid was washed with cold heptane (1 cake volume) and dried to give 1.269 kg solid (94% recovery)

 

https://i0.wp.com/dmd.aspetjournals.org/content/27/11/1319/F1.medium.gif

 

 

CLIPS

http://www.mdpi.com/1420-3049/21/2/221/htm

Molecules 21 00221 g003 1024

Molecules 21 00221 g004 1024

 

 

 

 

 

WO2007013047A2 * Jul 31, 2006 Feb 1, 2007 Ranbaxy Lab Ltd Water-dispersible anti-retroviral pharmaceutical compositions
WO2007013047A3 * Jul 31, 2006 May 31, 2007 Ranbaxy Lab Ltd Water-dispersible anti-retroviral pharmaceutical compositions
WO2007052289A2 * Jul 24, 2006 May 10, 2007 Rubicon Res Pvt Ltd Novel dispersible tablet composition
WO2007052289A3 * Jul 24, 2006 Dec 27, 2007 Rubicon Res Pvt Ltd Novel dispersible tablet composition
WO2011131943A2 Apr 20, 2011 Oct 27, 2011 Cipla Limited Pharmaceutical compositions
WO2012048884A1 Oct 14, 2011 Apr 19, 2012 Lonza Ltd Process for the synthesis of cyclic carbamates
WO2012048886A1 Oct 14, 2011 Apr 19, 2012 Lonza Ltd Process for the synthesis of cyclic carbamates
WO2015059466A1 Oct 22, 2014 Apr 30, 2015 Cipla Limited Pharmaceutical compositions comprising efavirenz
EP1448170A2 * Nov 26, 2002 Aug 25, 2004 Bristol-Myers Squibb Company Efavirenz tablet formulation having unique biopharmaceutical characteristics
EP2441759A1 Oct 14, 2010 Apr 18, 2012 Lonza Ltd. Process for the synthesis of cyclic carbamates
EP2447255A1 Oct 14, 2010 May 2, 2012 Lonza Ltd. Process for the synthesis of cyclic carbamates
US6238695 Apr 6, 1999 May 29, 2001 Dupont Pharmaceuticals Company Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
US6555133 Apr 2, 2001 Apr 29, 2003 Bristol-Myers Squibb Company Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
US8871271 Jul 29, 2013 Oct 28, 2014 Gilead Sciences, Inc. Method and composition for pharmaceutical product
US8957204 Oct 14, 2011 Feb 17, 2015 Lonza Ltd. Process for the synthesis of cyclic carbamates
US8969550 Oct 14, 2011 Mar 3, 2015 Lonza Ltd. Process for the synthesis of cyclic carbamates
US9018192 Oct 10, 2013 Apr 28, 2015 Bristol-Myers Squibb & Gilead Sciences, Inc. Unitary pharmaceutical dosage form
US9198862 Jul 24, 2006 Dec 1, 2015 Rubicon Research Private Limited Dispersible tablet composition
WO1995020389A1 * Jan 24, 1995 Aug 3, 1995 Merck & Co Inc Benzoxazinones as inhibitors of hiv reverse transcriptase
WO1996037457A1 * May 21, 1996 Nov 28, 1996 Merck & Co Inc Asymmetric synthesis of (-) 6-chloro-4-cyclopropyl-ethynyl-4-trifluoromethyl-1,4-dihydro-2h-3,1-benzoxazin-2-one
WO1998052570A1 * May 14, 1998 Nov 26, 1998 David Walter Barry Antiviral combinations containing the carbocyclic nucleoside 1592u89

References

  1. Gatch, M. B.; Kozlenkov, A.; Huang, R. Q.; Yang, W.; Nguyen, J. D.; González-Maeso, J.; Rice, K. C.; France, C. P.; Dillon, G. H.; Forster, M. J.; Schetz, J. A. (2013). “The HIV Antiretroviral Drug Efavirenz has LSD-Like Properties”. Neuropsychopharmacology 38 (12): 2373–84. doi:10.1038/npp.2013.135. PMC 3799056. PMID 23702798.
  • Sütterlin, S.; Vögele, C.; Gauggel, S. (2010). “Neuropsychiatric complications of Efavirenz therapy: suggestions for a new research paradigm”. The Journal of Neuropsychiatry and Clinical Neurosciences 22 (4): 361–369. doi:10.1176/jnp.2010.22.4.361.

External links

Efavirenz
Efavirenz.svg

 

 

Efavirenz.svg

Efavirenz ball-and-stick model.png
Systematic (IUPAC) name
(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one
Clinical data
Trade names Sustiva, Stocrin, others
AHFS/Drugs.com monograph
MedlinePlus a699004
Pregnancy
category
  • US: D (Evidence of risk)
Routes of
administration
By mouth (capsules, tablets)
Legal status
Legal status
  • UK: POM (Prescription only)
  • US: ℞-only
  • ℞ (Prescription only)
Pharmacokinetic data
Bioavailability 40–45% (under fasting conditions)
Protein binding 99.5–99.75%
Metabolism Hepatic (CYP2A6 and CYP2B6-mediated)
Onset of action 3–5 hours
Biological half-life 40–55 hours
Excretion Urine (14–34%) and feces (16–61%)
Identifiers
CAS Number 154598-52-4 Yes
ATC code J05AG03 (WHO)
PubChem CID 64139
DrugBank DB00625 Yes
ChemSpider 57715 Yes
UNII JE6H2O27P8 Yes
KEGG D00896 Yes
ChEBI CHEBI:119486 Yes
ChEMBL CHEMBL223228 Yes
NIAID ChemDB 032934
PDB ligand ID EFZ (PDBe, RCSB PDB)
Chemical data
Formula C14H9ClF3NO2
Molar mass 315.675 g/mol
1H NMR spectrum of C14ClF3H9NO2 in CDCL3 at 400 MHz
//////////////
FC([C@@]1(C#CC2CC2)OC(=O)Nc2c1cc(Cl)cc2)(F)F
Figure 1

42 Comments

  1. Valarie says:

    Still, if you have a graphic mind, this can be more useful than the more traditional list format.
    Topple: It involves stacking pieces as high as possible.
    East, West, Great Lakes, Florida, Texas, California and major rivers as well as non-U.

  2. Hi there to all, how is everything, I think every one is getting more from this website, and your
    views are pleasant in favor of new viewers.

  3. Really enjoyed this article, how can I make is so that I get
    an update sent in an email when there is a fresh update?

  4. Hi there this is somewhat of off topic but I was wondering if blogs use WYSIWYG
    editors or if you have to manually code with HTML.

    I’m starting a blog soon but have no coding knowledge so I
    wanted to get guidance from someone with experience.
    Any help would be greatly appreciated!

  5. The team went on to defeat Sweden 2-0 in the round of 16, with Lukas Podolski netting
    both goals in only 12 minutes, from assists by Miroslav Klose.
    Central midfielder – 17 – PSV – £3m – Dutch – DEMO. They may lack the motivation to invest personal energy in
    critical project work.

  6. These are really impressive ideas in concerning blogging.

    You have touched some good factors here. Any way keep up wrinting.

  7. Susanne says:

    Doodle Physics is very fun and challenging and is a must play physics game.
    The main idea is to enjoy and relax your mind so that it’s free of al tensions for some time.
    For this, hook the USB as many as both your computer and phone.

  8. Howdy! I could have sworn I’ve been to this website before but after looking at a few of
    the posts I realized it’s new to me. Anyways, I’m definitely pleased I discovered it and I’ll be bookmarking it and checking back frequently!

  9. Nice post. I was checking constantly this blog and I’m impressed!
    Extremely useful info specifically the last part :
    ) I care for such info a lot. I was looking for this certain information for
    a long time. Thank you and best of luck.

  10. Magnificent items from you, man. I have take note your stuff prior to and
    you are simply too magnificent. I actually like what you’ve acquired right here, certainly like what you’re stating
    and the way in which during which you are saying it.
    You’re making it entertaining and you continue to care for to keep it sensible.
    I can’t wait to learn much more from you.
    That is really a tremendous web site.

  11. Odell says:

    All that being said, the aspect to all of this that
    I wish to share, and perhaps provide a dose of
    caution, is: Grades. Thats the main reasons people dont usually set
    out to catch the Blue cat fish. Three years ago, the visual difference
    between a console game and an online game was staggering.

  12. I leave a response each time I like a post on a site or if I have something to contribute to the conversation.
    Usually it’s a result of the sincerness displayed in the
    post I browsed. And after this post EFAVIRENZ – Huahai Pharma China-Approved to Produce AIDS
    Treatment | New Drug Approvals. I was actually moved enough to post
    a thought🙂 I do have a few questions for you if it’s allright.

    Is it simply me or do some of the remarks look like they are left by brain dead people?😛 And, if you are writing at other sites, I’d like to
    follow you. Could you make a list every one of your community sites like your
    linkedin profile, Facebook page or twitter feed?

  13. The first thing you need to ask yourself when you’re looking at coach training
    programs is whether or not you need training in the first place.
    In the 1960s and 1970s, many students demonstrated against the government and hoped to
    make biog changes in society. He has also received recognition from Coastal Business Life Magazine and
    Golf Digest, and his golf tips have appeared in
    USA Today.

  14. mode in this game, with a lame game that had a shortage of characters and awkward control like this doesn’t even worth playing a good
    one on one vs. These packs usually consist of different outfits for your character to wear.
    The all-star King of Fighters series seemed to get better with each
    release and the mash-ups of fighters from different SNK games got more and more flawless year by year.

  15. ) It stimulates the immune system with very high levels of beta-carotene (4
    Milligram. especially for warmer water baits and through into the autumn time.
    Three years ago, the visual difference between a
    console game and an online game was staggering.

  16. Explosive Melee Attacks – PS3: Right, Left, X, Triangle, R1, Circle,
    Circle, Circle, L2Xbox 360: Right, Left, A, Y, RB, B,
    B, B, LT. There is no doubt that Grand Theft Auto San Andreas is an exciting game.
    The fanny magnet cheat code will force girls to
    follow you closely, and the pedestrians have weapons cheat code will
    do what the title tells you.

  17. It is a very bad idea for a person to represent themselves in
    a criminal case. This could mean he came from Mexico and went to the USA for a better life.
    The good part of the game is that you can undergo different experiences while playing it such
    as being a first person shooter, a third person shooter, and you
    can ride your car and what not.

  18. Michele says:

    You’re so cool! I dont suppose Ive read anything
    like this before. So nice to find a person with some original thoughts
    on this subject. really thank you for starting this up.
    this website is one thing that’s wanted online, somebody with a bit
    of originality. good job for bringing new things to the internet!

  19. In other words, this school differs from other training schools who take a more cookie-cutter approach to training, and do not engage each dog on an individual and personal level.
    To make a nice tall cookie Christmas tree you start by baking 5 cookies (I used a
    plain sugar cookie recipe) per each size star in a set of 6 or
    7 graduated star cookie cutters. These books are a need to have for any
    child and you will not regret having them, however they do cost
    a pretty penny.

  20. Congratulations, you’re blogging-along with hundreds of
    thousand of others in the vast space of the Internet. It takes tenacity and consistency to
    just keep at it. Choose an easy-to-read font and font color,
    and add any gadgets or whatever that you want to your blog.

  21. Youtube.com says:

    Would parents than have to designate time spent in the bathroom.

    Furthermore, while the updates are named different
    on each platform, the patches are also numbered similarly to
    avoid confusion. Apparently, from what he told me about the success, and you
    can have your own free Minecraft accounts.

  22. Yes! Finally something about roof jacks for metal roofs.

  23. Hi, yes this article is really nice and I have learned lot of things from
    it regarding blogging. thanks.

  24. We’re a bunch of volunteers and opening
    a brand new scheme in our community. Your site provided us
    with helpful info to work on. You have done an impressive process and our entire community might
    be grateful to you.

  25. I like the valuable information you supply in your articles.
    I’ll bookmark your weblog and test once more
    right here regularly. I am relatively sure I will be told a lot
    of new stuff right here! Good luck for the following!

  26. Use Dropbox As Web Host says:

    Hmm it seems like your blog ate my first comment (it was extremely long) so I guess
    I’ll just sum it up what I had written and say, I’m thoroughly
    enjoying youir blog. I as welkl am an aspiring log blogger but I’m still new
    to the whole thing. Do you have any recommendations
    for novice blog writers? I’d genuinely appreciate it.

  27. Ruby for IIS does some patching to Rails and Ruby to
    allow IIS to route its requests to Fast – CGI and eventually to Rails.
    enjoy. This software package easily helps user with the topic of
    sharing Microsoft office documents between teams and making those documents more available
    through with search.

  28. Channing Tatum spent a good bit of time on movie sets in Louisiana during 2011.
    Casting agents post their reality TV show casting at websites like
    these, first. Customarily it is probable that the price is a bit on the higher end.

  29. Have you ever thought about writing an e-book or
    guest authoring on other sites? I have a blog based
    upon on the same subjects you discuss and would love to have you share some stories/information. I know
    my subscribers would enjoy your work. If you are even remotely interested, feel free to send me an e-mail.

  30. wine stains says:

    During this period, nothing should be grown in between these vines.
    – Beware of the words caution, warning, and danger.
    This is important because Kashrut law states that any wine that is opened by someone who is
    not a Jew, it loses its religious purity.

  31. Marvelous, what a website it is! This web site presents useful facts to
    us, keep it up.

  32. you are in point of fact a good webmaster. The website loading velocity is incredible.
    It seems that you’re doing any unique trick. Furthermore,
    The contents are masterpiece. you’ve done a excellent task on this matter!

  33. brochures says:

    Hey there! Do you know if they make any plugins to assist with SEO?

    I’m trying to get my blog to rank for some targeted keywords but I’m not seeing very good results.
    If you know of any please share. Cheers!

  34. Wifi Hacker says:

    Hmm it looks like your website ate my first comment (it was extremely long) so I guess I’ll just sum it up what I wrote and say, I’m thoroughly enjoying your
    blog. I too am an aspiring blog writer but I’m
    still new to everything. Do you have any recommendations for inexperienced blog writers?

    I’d certainly appreciate it.

  35. Gamelara.com says:

    Hey there! This post couldn’t be written any better!
    Reading through this post reminds me of my good old room mate!
    He always kept chatting about this. I will forward this write-up to
    him. Fairly certain he will have a good read. Thank you for sharing!

  36. epoxy says:

    Excellent beat ! I would like to apprentice while you amend your site, how
    could i subscribe for a blog web site? The account aided me a acceptable deal.
    I had been a little bit acquainted of this your broadcast provided
    bright clear concept

  37. I’m really enjoying the theme/design of your blog.
    Do you ever run into any web browser compatibility
    issues? A few off my blog readers have complained about my blog
    not working correctly in Explorer but looks great in Opera.
    Do you have any solutions to help fix this issue?

  38. remedies says:

    This is the perfect web site for anybody who wishes to understand this topic.
    You understand a whole lot its almost tough to argue with you (not that
    I personally will need to…HaHa). You definitely put a
    new spin on a topic that’s been written about for years.
    Excellent stuff, just excellent!

  39. continuously i used to read smaller articles or reviews that as well clear their motive, and that is also happening with this piece of writing which I amm reading here.

  40. Can I just say what a relief to find an individual who really understands
    what they’re talking about on the web. You definitely know how to bring a problem to light and make it important.
    More and more people ought to check this out and understand this side of your
    story. I was surprised you aren’t more popular given that you
    definitely have the gift.

  41. espadrilles says:

    Spot on with this write-up, I truly believe this site needrs ffar more attention. I’ll probably be bafk again to read through more, thanks for the info!

  42. Good waay off explaining, and fastidious pice of writing to obtain facts on the topic of my presentation focus, which i aam going to present in university.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Paypal Donate

DR ANTHONY CRASTO

Follow New Drug Approvals on WordPress.com

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 1,782 other followers

DR ANTHONY MELVIN CRASTO Ph.D

DR ANTHONY MELVIN CRASTO Ph.D

DR ANTHONY MELVIN CRASTO, Born in Mumbai in 1964 and graduated from Mumbai University, Completed his Ph.D from ICT, 1991,Matunga, Mumbai, India, in Organic Chemistry, The thesis topic was Synthesis of Novel Pyrethroid Analogues, Currently he is working with GLENMARK PHARMACEUTICALS LTD, Research Centre as Principal Scientist, Process Research (bulk actives) at Mahape, Navi Mumbai, India. Total Industry exp 29 plus yrs, Prior to joining Glenmark, he has worked with major multinationals like Hoechst Marion Roussel, now Sanofi, Searle India Ltd, now RPG lifesciences, etc. He has worked with notable scientists like Dr K Nagarajan, Dr Ralph Stapel, Prof S Seshadri etc, He did custom synthesis for major multinationals in his career like BASF, Novartis, Sanofi, etc., He has worked in Discovery, Natural products, Bulk drugs, Generics, Intermediates, Fine chemicals, Neutraceuticals, GMP, Scaleups, etc, he is now helping millions, has 9 million plus hits on Google on all Organic chemistry websites. His friends call him worlddrugtracker. His New Drug Approvals, Green Chemistry International, All about drugs, Eurekamoments, Organic spectroscopy international, etc in organic chemistry are some most read blogs He has hands on experience in initiation and developing novel routes for drug molecules and implementation them on commercial scale over a 29 year tenure till date Aug 2016, Around 30 plus products in his career. He has good knowledge of IPM, GMP, Regulatory aspects, he has several International patents published worldwide . He has good proficiency in Technology transfer, Spectroscopy, Stereochemistry, Synthesis, Polymorphism etc., He suffered a paralytic stroke/ Acute Transverse mylitis in Dec 2007 and is 90 %Paralysed, He is bound to a wheelchair, this seems to have injected feul in him to help chemists all around the world, he is more active than before and is pushing boundaries, He has 9 million plus hits on Google, 2.5 lakh plus connections on all networking sites, 25 Lakh plus views on dozen plus blogs, He makes himself available to all, contact him on +91 9323115463, email amcrasto@gmail.com, Twitter, @amcrasto , He lives and will die for his family, 90% paralysis cannot kill his soul., Notably he has 13 lakh plus views on New Drug Approvals Blog in 212 countries......https://newdrugapprovals.wordpress.com/ , He appreciates the help he gets from one and all, Friends, Family, Glenmark, Readers, Wellwishers, Doctors, Drug authorities, His Contacts, Physiotherapist, etc

Personal Links

View Full Profile →

bloglovin

Follow my blog with Bloglovin The title of your home page You could put your verification ID in a comment Or, in its own meta tag Or, as one of your keywords Your content is here. The verification ID will NOT be detected if you put it here.
%d bloggers like this: